Verition Fund Management LLC Cor Medix Inc. Transaction History
Verition Fund Management LLC
- $20.3 Billion
- Q2 2025
A detailed history of Verition Fund Management LLC transactions in Cor Medix Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 23,428 shares of CRMD stock, worth $275,044. This represents 0.0% of its overall portfolio holdings.
Number of Shares
23,428
Previous 40,792
42.57%
Holding current value
$275,044
Previous $251,000
14.74%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CRMD
# of Institutions
185Shares Held
32.9MCall Options Held
867KPut Options Held
561K-
Vanguard Group Inc Valley Forge, PA4.33MShares$50.8 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.55MShares$41.7 Million0.0% of portfolio
-
Marshall Wace, LLP London, X02.58MShares$30.3 Million0.04% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.71MShares$20.1 Million0.0% of portfolio
-
State Street Corp Boston, MA1.6MShares$18.8 Million0.0% of portfolio
About CorMedix Inc.
- Ticker CRMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,208,200
- Market Cap $484M
- Description
- CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of cathet...